Strados Labs supports clinical trials in collecting real-world respiratory data for measuring primary and exploratory endpoints. Strados Labs’ RESP™ Biosensor is a first-of-its-kind respiratory wearable that continuously captures 24-hour cough frequency and lung sound events such as wheezing and crackles associated with chronic respiratory diseases (CRDs). Data captured by our patient-friendly device is sent wirelessly to the cloud, making it a seamless experience for home use in decentralized clinical trials. We are committed to helping pharmaceutical sponsors collect stronger evidence for their treatments, reduce data variability and bring life-saving drugs to market faster with objective and novel measures. RESP Biosensor is FDA-cleared, CE mark approved, and clinically validated with ten supporting abstracts featured by leading respiratory societies. Our technology is currently being used to monitor cough in clinical trials across Europe and Asia.